, the role of Sip1 in axonal growth and navigation has not been dissected. Based on their origin and projection site, neocortical axons can be broadly classified as intercortical and corticofugal projections (Molyneaux et al., 2007) . Intercortical connections include the CC and the anterior commissure (AC). The corticofugal connections include the corticothalamic tract (CT) and the corticospinal tract (CST) (Fame et al., 2011) . Apart from these long-range projections, ipsilateral intracortical connections are also present that help in coordinating information within the cortical hemisphere. Understanding the cellular and molecular mechanisms governing the establishment of these connections is important for understanding brain function (Courchet et al., 2013; Wang et al., 2007) . In this study we have examined the role of the transcription factor Sip1 in establishing cortical connections. We show that Sip1 is not only required for CC formation but also contributes to the establishment of other cortical axonal tracts like AC and CST. Sip1 acts cell-autonomously to control CC and CST formation by regulating axonal growth rate. Sip1 also controls ipsilateral axonal collateral formation in vivo. Furthermore, we identified ninein, a microtubule (MT) minus-end binding protein, to be a direct target of Sip1 transcriptional regulation. Through ninein gain-and loss-of-function experiments we have shown that ninein controls axonal growth rate in cortical projection neurons. We further show that ninein in turn can stabilize MTs and facilitate MT growth rate in cortical neurons.
In Brief Srivatsa et al. have shown that the transcription factor Sip1 controls the rate of axonal elongation and branch formation in neocortical neurons. It acts through its direct downstream effector ninein, which in turn alters microtubule stability and dynamics within the axons.
INTRODUCTION
Sip1 (Zfhx1b, Zeb2) is a zinc-finger transcription factor whose heterozygous mutations cause the Mowat-Wilson syndrome (MWS) in humans. MWS patients are characterized by multiple congenital abnormalities, intellectual disability, and epilepsy, frequently accompanied by agenesis of the corpus callosum (CC) (Garavelli and Mainardi, 2007; Wilson et al., 2003) . Within the mouse neocortex, onset of Sip1 expression corresponds to the appearance of the first set of postmitotic cells at E12.5 and expands with the expansion of the cortical plate (CP) (Seuntjens et al., 2009) . Sip1 deletion in the mouse CNS during development was shown to cause multiple developmental disturbances including hippocampal degeneration (Miquelajauregui et al., 2007) , abnormal specification of cortical pyramidal neurons and interneurons (McKinsey et al., 2013; Seuntjens et al., 2009; van den Berghe et al., 2013) , and abnormal myelination (Weng et al., 2012) . Although it has been reported that both MWS patients and Sip1-deficient mice show agenesis of the CC (Miquelajauregui et al., 2007) , the role of Sip1 in axonal growth and navigation has not been dissected. Based on their origin and projection site, neocortical axons can be broadly classified as intercortical and corticofugal projections (Molyneaux et al., 2007) . Intercortical connections include the CC and the anterior commissure (AC). The corticofugal connections include the corticothalamic tract (CT) and the corticospinal tract (CST) (Fame et al., 2011) . Apart from these long-range projections, ipsilateral intracortical connections are also present that help in coordinating information within the cortical hemisphere. Understanding the cellular and molecular mechanisms governing the establishment of these connections is important for understanding brain function (Courchet et al., 2013; Wang et al., 2007) . In this study we have examined the role of the transcription factor Sip1 in establishing cortical connections. We show that Sip1 is not only required for CC formation but also contributes to the establishment of other cortical axonal tracts like AC and CST. Sip1 acts cell-autonomously to control CC and CST formation by regulating axonal growth rate. Sip1 also controls ipsilateral axonal collateral formation in vivo. Furthermore, we identified ninein, a microtubule (MT) minus-end binding protein, to be a direct target of Sip1 transcriptional regulation. Through ninein gain-and loss-of-function experiments we have shown that ninein controls axonal growth rate in cortical projection neurons. We further show that ninein in turn can stabilize MTs and facilitate MT growth rate in cortical neurons.
closure was complete and was comparable to the controls ( Figure 1A ). To further characterize the neocortical connectivity defects in the Sip1 mutant, we performed carbocyanine dye tracing by placing DiI crystals in the somatosensory, motor, and visual cortex of control and Sip1 mutant brains harvested 
Nex
Cre brains show defects in dorsal midline closure. Higher-magnification images correspond to the boxed regions. Dotted and solid lines indicate unfused and fused regions of the midline, respectively. In the Sip1 fl/wt Nex Cre brains, while the midline dorsal to the CC remains unfused (red dotted line), midline fusion has taken place in the region of the CC crossing (blue line) and further ventrally (green line). In the Sip1 mutant brains the entire dorsal midline remains unfused (red and blue dotted line, arrows). Ventral fusion is complete (green line). Scale bars, 1 mm (lowermagnification images), 0.5 mm (higher-magnification images).
(B) Anterograde DiI labeling from the putative somatosensory and motor cortex at P5 confirms the absence of the CC in the Sip1 mutant. The corticothalamic tract (CT) is unaffected. The CST is almost absent in the Sip1 mutant brains, with almost no fibers passing through the CP. (C) Retrograde DiI labeling from the thalamus and CP reconfirms the presence of CT and absence of CST axons, respectively, in the Sip1 mutants. Inset boxes show crystal placement. Scale bars, 1 mm (lower magnification images), 0.5 mm (high-magnification images) (see also Figure S1 ). NCx, neocortex; Th, thalamus.
at P5. Tracing confirmed the absence of the CC in the mutants ( Figure 1B ). Examining the corticofugal connections in the Sip1 mutant revealed that CT was unaltered, as axons could be traced passing through the internal capsule into the thalamus. Back-labeled thalamic neurons could also be visualized indicating the presence of intact thalamo-cortical fibers (TC) ( Figure 1B) . CST, on the other hand, was completely absent in the Sip1 mutants, where almost no axons could be seen passing through the cerebral peduncle (CP) ( Figure 1B ). The presence of the CT and absence of the CST in the Sip1 mutant was also confirmed by retrograde DiI tracing from the ventrobasal complex of the thalamus and the CP, respectively, at P5. In the control brains, layer VI, VIb, and V neurons were back-labeled from the thalamus, and layer V neurons were exclusively back-labeled from the CP. On the other hand, in the Sip1 mutant brains, while layer VI, VIb, and V neurons were back-labeled from the thalamus, hardly any layer V neurons could be back-labeled from the CP (legend continued on next page) ( Figure 1C ). Previous work from our laboratory showed that due to non-cell-autonomous effects of Sip1 deletion, deep-layer neurons are reduced in the Sip1 mutants when compared to controls (Seuntjens et al., 2009) . To verify whether the loss of the CST was due to the reduction in layer V population, we immunostained the back-labeled sections against Ctip2. Colocalizing Ctip2-positive and DiI-positive cells showed that, although reduced, a significant number of Ctip2-positive layer V neurons were present in the Sip1 mutant but failed to project through the CST. This indicated that the lack of formation of the CST was not due to the absence of layer V neurons but rather to projection defects ( Figure S1B a marker of apoptotic cell death, at E18.5 showed that there was no apparent cell death in the Sip1 mutant cortex compared to the control ( Figure S1C ).
Mosaic Deletion of Sip1 Affects CC and CST Formation
While the lack of dorsal midline closure in the Sip1 mutants might be involved in causing the absence of CC, we wanted to determine if Sip1 also played a cell-autonomous role in the formation of cortical projections. We electroporated a GFP-IRES-Cre plasmid expressed under the ubiquitin promoter in Sip1 fl/wt and Sip1 fl/fl embryos at E12.5 and harvested the embryos at E18.5. We confirmed the mosaic deletion of Sip1 in the Creexpressing cells in the Sip1 fl/fl cortex ( Figure S2 ). This approach made it possible to study the in vivo behavior of mutant axons within a wild-type environment. While the GFP-positive axons in the Sip1 fl/wt embryos could be traced passing through the CC into the contralateral hemisphere, the Cre/GFP-positive and hence Sip1-negative axons in the Sip1 fl/fl embryos could not form the CC, and almost no GFP-positive fibers could be detected at the midline ( Figure 2A ). It is noteworthy that Sip1-negative/GFP-positive fibers in the Sip1 fl/fl brain were unable to project across the midline even though GFP negative; wildtype axons (stained with anti-L1 antibody) formed an intact CC. Since neurons from layer V as well as UL neurons contribute to the formation of the CC (Fame et al., 2011; Srivatsa et al., 2014) , electroporation of GFP-IRES-Cre at E12.5 would target a subset of both these populations. Thus, the cell-autonomous requirement of Sip1 for the formation of the CC applies to callosally projecting neurons of all layers. Quantifying the relative fluorescence area of the callosal axons crossing the midline with respect to the fluorescence area of the electroporated region showed a 99% decrease in Sip1 fl/fl embryos when compared to Sip1 fl/wt embryos ( Figure 2A ). cating that in the absence of Sip1 the CST was also not formed ( Figure 2B ). In order to determine if the lack of CC and CST at E18.5 and E17.5, respectively, in the Sip1 fl/fl mice was due to a delay in the axonal growth of Sip1-deficient neocortical neurons, we electroporated Sip1 fl/fl and Sip1 fl/wt brains with GFP-IRESCre at E12.5 and harvested the brains at P7. In these experiments Sip1-deficient callosal fibers formed both the CC and the CST ( Figure 2D) . Therefore, Sip1 cell-autonomously controls axonal growth rate but not axonal navigation, as the defects in CC and CST formation were not observed at later developmental stages.
Sip1-Deficient UL Neurons Show Defects in the Formation of Intracortical Axon Collaterals UL neurons, apart from projecting to the contralateral cortex through the CC and making synaptic contacts with contralateral neurons, also form axonal branches and hence synaptic connections with ipsilateral layer V neurons (Burkhalter, 1989; Kritzer and Goldman-Rakic, 1995; Thomson and Lamy, 2007) . Since the lack of Sip1 affected axonal growth through the CC and CST, we wanted to test whether Sip1 deficiency also affects the formation of ipsilateral axonal collaterals. First, in order to investigate the normal course of collateral formation of UL neurons on layer V, we electroporated an eGFP expressing plasmid at E15.5 in wild-type neocortex and harvested the embryos subsequently at postnatal stages ranging from P0 to P7. We observed that between P0 and P3 as the UL neurons migrate into the CP and take up their final position in the cortex, they project axons to the white matter (WM) with no visible axonal collaterals. By P4, the first branches of ipsilateral axonal collaterals could be seen at the level of layer V, demarcated by Ctip2-positive cells ( Figure 3A) . Between P4 and P7, there was a steady increase in the density of these axonal branches. Hence, ipsilateral branching of UL axons commences at P4 and is very prominent at P7 ( Figure 3A) .
We then electroporated a GFP-IRES-Cre plasmid into Sip1 fl/fl and Sip1 fl/wt embryos at E15.5 and harvested the pups at P7, a stage when the ipsilateral axonal collaterals are normally well established. We observed that while the axons in the Sip1 fl/wt cortex branched to form a dense network at layer V, Sip1 lacking UL neurons in the Sip1 fl/fl brains were seen sending axons to the WM without forming collaterals at layer V ( Figure 3B ). We quantified the fluorescent area of the axonal collateral at layer V within a radial unit relative to the number of electroporated neurons and observed a 5. Sip1-deficient neurons project through the CP (see also Figure S2 ).
( Figure 3C ). In order to determine if the lack of formation of the axonal branches at P7 was due to a delay in branch formation similar to the axonal growth delay, we electroporated GFP-IRES-Cre at E15.5 in Sip1 fl/fl and Sip1 fl/wt embryos and analyzed the brains at P14. We observed that at this stage the Sip1-deficient UL neurons formed ipsilateral axon collaterals at layer V, comparable to corresponding Sip1 fl/wt brains ( Figure S3 ). Therefore, these experiments indicate that Sip1 cell-autonomously controls the timing of intracortical axonal branch formation.
Sip1 Controls the Expression of the MicrotubuleAssociated Protein ninein through Direct Binding to the ninein Enhancer
In order to identify Sip1 targets that control axonal growth and collateral formation, we studied previously performed and pub- lished microarray analysis conducted at E14.5 to identify genes with altered expression in the Sip1 deficient cortex (GEO accession number GSE16699; Seuntjens et al., 2009 ). Since Sip1 deletion had effects on both DL neurons (CC and CST forming) and UL neurons (CC and ipsilateral collateral forming), we presumed that analyzing differential expression of genes at E14.5 could reveal a potential target. We initially restricted our search to candidates that belong to axon guidance molecules or cytoskeletal proteins, as these groups of molecules have previously been shown to affect axon growth, guidance, and branching. The microarray analysis revealed that ninein, a centrosome and MT minus-end binding protein, was downregulated in the absence of Sip1. We verified this finding by performing an immunohistological staining with an anti-ninein antibody on E16.5 control and Sip1 fl/fl Nex Cre/wt embryos. Within the wild-type neocortex, ninein was strongly expressed in the CP with no laminar restriction and in the ventricular zone (VZ) ( Figure 4A ). Expression of ninein was also detected within the WM in the control brains. In the Sip1 fl/fl Nex Cre/wt mutant, a severe downregulation of ninein expression in the CP as well as in the WM of the cortex could be observed. The expression of ninein in the VZ, where neither Sip1 nor Nex is expressed, was unaltered ( Figure 4A ). To test the expression of ninein at postnatal stages relevant to layer V axon collateral formation, we performed western blot analysis on cortical lysates from P0, P3, P4, and P7 brains. Ninein was expressed in all the stages tested ( Figure S4A ).
To test whether Sip1 activates ninein expression directly or indirectly, we performed chromatin immunoprecipitation (ChIP) assay with an anti-Sip1 antibody on wild-type and Sip1 mutant cortices. The immunoprecipitated chromatin was analyzed through qRT-PCR for the presence of six different genomic regions, denoted as Nin-P1 to Nin-P6 within 25 Kb upstream of the ninein transcription start site (TSS). These regions contained the Sip1 consensus binding sequence CACCT(G) (Verschueren et al., 1999) . The ChIP assay showed 7-to 10-fold enrichment in all six regions tested with wild-type tissue ( Figure 4B ). Sip1 mutant cortex showed no enrichment. We also tested for Sip1 enrichment in the Fgf9 enhancer region. Fgf9 was previously shown to be upregulated in the Sip1 mutant but not to be a direct target (Seuntjens et al., The most proximal enhancer element was cloned upstream of gaussia luciferase called GLNin-P6. A 2.6-fold increase in relative luminescence on Sip1 binding was observed. Mean ± SD; GLuc = 0.039 ± 0.006, GLuc + Sip1 = 0.012 ± 0.001, n = 3; GL-Nin-P6 = 5.96 ± 0.990, GL-Nin-P6 + Sip1 = 15.72 ± 0.242; p value = 0.002, n = 3 (Student's t test) (see also Figure S4 ).
2009). We did not observe any enrichment at this locus ( Figure 4B ). To test the functionality of this binding, we performed luciferase assay in HEK293T cells with the ninein enhancer region most proximal to the TSS that was positive for Sip1 binding, i.e., Nin-P6. In the presence of Sip1, Nin-P6 showed a significant upregulation of luciferase activity (2.6-fold), thus confirming the functionality of Sip1 binding to the ninein locus ( Figure 4C ). Since distal genomic regions also showed Sip1 binding, we further tested the functional relevance of Sip1 binding to Nin-P1 and Nin-P4. In the presence of Sip1, Nin-P1 showed a significant downregulation ($5.6-fold) of luciferase activity, while Nin-P4 did not show any significant change ( Figure S4B ). These experiments together showed that Sip1 activates ninein expression through direct binding and that binding to a specific site close to the TSS is essential for Sip1 to function as a transcriptional activator. It is also probable that the distal elements might not even belong to the active enhancer region, owing to their distance from the TSS or that the coactivator complex required for Sip1 to activate the transcription of ninein binds specifically to the proximal region.
Ninein Is Present in All Cytoskeletal Compartments of Cortical Neurons and Influences Axonal Elongation In Vitro
It has been previously shown through expression of GFP-tagged ninein or using an anti-ninein antibody that ninein localizes to the somatodendritic compartment of neurons (Baird et al., 2004; Ohama and Hayashi, 2009 ). Since apart from the CP and VZ we also detected expression of ninein in the WM of the wildtype cortex at E16.5 ( Figure 4A ), we wanted to test if ninein also localizes to the axon and the axonal growth cone. Hence, a plasmid expressing eGFP tagged ninein was cotransfected with a plasmid expressing dsRed into dissociated cortical neurons at DIV 1 (first day in vitro) and analyzed at DIV 2 or DIV 7. We observed that at DIV 2 eGFP-Ninein puncta were localized to the soma, dendrites, axon, and axonal growth cone ( Figure 5A ). Examining DIV 7 neurons also revealed a similar distribution of ninein ( Figure 5B ). Thus in addition to localizing to the dendrites and the soma, ninein also localizes to axons and axonal branches. We wanted to test if ninein, being an MT binding protein that localizes to the axon and is downregulated in the Sip1 mutant, could influence axonal elongation. First we tested if Sip1 deletion from neocortical neurons would affect axonal length in vitro. Sip1 fl/wt and Sip1 fl/fl embryos were electroporated with a GFP-IRES-Cre plasmid at E14.5 and the brains were isolated at E17.5. The electroporated region of the cortex was isolated and dissociated, and neurons were cultured for 2 days in vitro. In utero electroporation (IUE) was used instead of plasmid transfection in order to delete Sip1 as early as possible. The neurons were immunostained with antibodies against GFP and tau-1 to demarcate the axon. We observed that the average length of the axon of Sip1-deficient neurons was significantly shorter when compared to wild-type neurons, thus reconfirming the cell-autonomous requirement of Sip1 for axon growth ( Figure 5C Figure S5B ) . Expressing ninein in Sip1-deficient cells significantly increased the average length of the axon when compared to Sip1-negative neurons, although it was not restored to wild-type levels ( Figure 5C ). We additionally performed ninein gain-of-function experiments by expressing ninein in wild-type neurons and measuring their axon length at DIV2. We observed that overexpression of ninein marginally increases the average length of the axons ( Figure S5C ). Figure S6A ).
Restoration of ninein Expression in
Expressing ninein in the Sip1-deficient cells could rescue the CC, as the electroporated neurons were able to project their axons, across the midline into the contralateral hemisphere. Similar to the in vitro rescue of axonal length, the in vivo rescue of the CC was partial, as both the proportion of GFP-positive axons crossing the midline and maximal axonal length at E18.5 were not restored to wild-type levels. Unlike the in vitro experiments, there was no significant difference in CC thickness between control and ninein overexpressing wild-type brains ( 6D ).
Downregulation of ninein Expression Phenocopies the Effects of Sip1 Loss, Both In Vitro and In Vivo
To address the role of ninein in axon growth and branching directly, we performed in vitro and in vivo loss-of-function experiments using an shRNA against ninein. The efficiency of ninein downregulation by the shRNA used has been previously validated (Wang et al., 2009 ). Cortical neurons expressing plasmids encoding shNinein and eGFP were dissociated and the lengths of the axons were measured at DIV 2. An shRNA against luciferase (shLuc + eGFP) was used as a control. Similar to Sip1-negative neurons, ninein loss-of-function neurons also showed stunted axonal growth when compared to the controls ( Figure 7A ). To further evaluate the effect of silencing ninein in vivo, we electroporated shNinein or shLuc in wild-type embryos at E13.5 and analyzed the brains at E17.5 for the formation of CC and CST. By E17.5, while shLuc-expressing neurons projected through the CC and across the midline, most shNinein expressing neurons could not ( Figure 7B ). Examining caudal sections also showed a similar effect on the CST, where GFPpositive axons could not be detected at the level of the CP in case of shNinein electroporation ( Figure S7 ). These observations were similar to the effects of mosaic deletion of Sip1 (Figures 2A  and 2B ). Furthermore, IUE of shLuc + eGFP or shNinein + eGFP at E15.5 and analysis of the brains at P7 showed that while shLuc-expressing neurons extended a robust mesh of axonal branches at layer V ipsilaterally, ninein-silenced neurons showed significantly lesser branching ( Figure 7C ). Comparing these results with Sip1-negative neurons ( Figure 3B ) confirmed that direct downregulation of ninein has an effect on axonal branching similar to that of the loss of Sip1.
Slower Microtubule Growth Contributes to the Stunted Growth of Sip1-Deficient Axons and Is Controlled by ninein Growth rate of the axon to a large extent is dependent on the growth and dynamics of inner cytoskeletal scaffold formed by MTs (Conde and Cá ceres, 2009) . We hypothesized that Sip1 may control the growth rate of axonal MTs through ninein. To assess this, we used the MT plus-end binding protein EB3 fused with GFP and tracked GFP-EB3 comets through live-imaging experiments (Stepanova et al., 2003) . Cre-and
GFP-EB3-expressing Sip1
fl/wt or Sip1 fl/fl cortical neurons were cultured at E16.5 and imaged at DIV 2. GFP-EB3 comets from 13 to 16 neurons were analyzed per condition, and only the comets that could be tracked for 10 s or more were included in the analysis. The average anterograde velocity of GFP-EB3 comets was significantly reduced in Sip1-deficient neurons ( Figure 8A ; Movie S1 and Movie S2). When we examined axons of Sip1-deficient neurons where ninein expression was restored (Sip fl/fl neurons expressing Cre + Ninein + GFP-EB3), we observed that the average anterograde velocity of GFP-EB3 comets was significantly higher than in the axons of Sip1-deficient neurons and was almost restored to wild-type levels ( Figure 8A ; Movie S3). Figure S6 ).
Ninein Influences the Stability of Axonal Microtubules
Apart from MT growth, MT stability is another important factor that alters the underlying cytoskeleton in a cell. To understand whether ninein also contributes to the stability of the MTs, we performed nocodazole-mediated MT breakdown assay with Sip1 fl/fl neurons expressing either GFP-IRES-Cre or GFP-IRES-Cre + ninein and with wild-type neurons expressing either eGFP or eGFP + ninein or eGFP + shNinein. These groups of neurons were exposed to 5 mM nocodazole for 2, 4, 6, and 8 hr, after which they were fixed and stained for acetylated tubulin (ac-tub), which labels stable MTs. The proportion of cells that showed positive ac-tub staining within the axon and the other neurites was counted. GFP and ac-tub co-staining on eGFP and eGFP + ninein-expressing wild-type neurons at 2 and 8 hr are shown as examples ( Figure 8B ). (B) E17.5 wild-type brains electroporated with shLuc + eGFP or shNinein + eGFP at E13.5 show that unlike the axonal projections of shLuc expressing neurons, which crossed the midline, the axonal projections of shNinein expressing neurons failed to do so. Quantification of the fluorescence area at the midline relative to the electroporated fluorescence area, mean ± SD: shLuc (n = 4) = 0.692 ± 0.0566, shNinein (n = 3) = 0.0094 ± 0.0031, p value < 0.001 (Student's t test).
(C) IUE of shLuc + eGFP or shNinein + eGFP at E15.5 in wild-type embryos and analysis at P7 shows that unlike the control brains, shNinein expressing neurons do not form robust ipsilateral axon collaterals at layer V. The higher-magnification images correspond to the boxed region in Layer V. Scale bar, 200 mm. Quantification of the extent of branching at the level of layer V relative to the number of cells electroporated, mean ± SD: shLuc (n = 4) = 965.168 ± 42.269, shNinein (n = 4) = 340.184 ± 86.160, p value < 0.001 (Student's t test) (see also Figure S7 ). ure 8B). Therefore, ninein positively influences the stability of MTs and Sip1 acts through ninein to affect MT stability in cortical neurons. Additionally we also compared the ratio of the levels of acetylated tubulin (ac-tub) to the levels of tyrosinated tubulin (tyr-tub) through western blot analysis on E16.5 wild-type and Sip1 fl/fl Nex Cre/wt cortical lysates.
While ac-tub is used as a marker for stable MTs, tyr-tub indicates the unstable MT population. Although we did not detect a significant change in the ratios between wild-type and Sip1 mutant, the trend indicated a slight decrease in the Sip1 mutant ( Figure S8 ).
DISCUSSION
Sip1 is a transcription factor that was shown to be a key regulator of critical developmental processes in the forebrain (McKinsey et al., 2013; Miquelajauregui et al., 2007; Nityanandam et al., 2012; Seuntjens et al., 2009; van den Berghe et al., 2013 ). Here we demonstrate that Sip1 also controls another critical developmental process, the formation of neocortical projections. Multiple cortical axonal tracts are affected in the Sip1 mutant. Sip1-deficient mice do not form CC, AC, and CST, while the CT tract does not seem to be affected. At least with respect to CC, CST, and HC projection neurons, Sip1 deficiency has a cell-autonomous impact on the growth rate of axons. Whether a similar mechanism is involved in the formation of the AC as well remains to be investigated. In this study we have used mosaic deletion of Sip1 from neocortical neurons in order to detect the axon outgrowth defects with respect to the CC and CST in vivo. Using a similar technique for studying the AC was challenging and inconclusive, as electroporations of the piriform cortex were very inconsistent in terms of extent and localization rostrocaudally. This, added to the fact that loss of Sip1 affects the rate of growth of axons and not the axonal extension per se, made it extremely difficult to evaluate, in an unbiased manner, the extent of projection within the AC. Nevertheless, we think that since neither the expression of Sip1 nor the expression of its downstream effector, ninein, is restricted to a specific subpopulation of cells within the CP at the time of cortical axonogenesis, and a similar mechanism seems to be controlling both commissural (CC) and corticofugal projections (CST), it is likely that such a Sip1-mediated cell-autonomous mechanism could be a more general phenomenon, not restricted to one kind of projection neuron. That said, the reason for CT projections to be the only cortical axonal tract unaffected in the Sip1 mutant remains to be understood. Limited by our current knowledge, we can only speculate that this might be owing to CT axons being the only projections that rely on Sip1-independent noncortical axons (thalamocortical afferents) to aid in tract formation (Deck et al., 2013; Nishizaki et al., 2014 
Nex
Cre/wt mutants, while CC is not. These discrepancies might be attributed to the midline closure defects observed in the Sip1 fl/fl Nex Cre/wt mutant and not in the mosaic deletion model, probably occurring due to non-cell-autonomous effects of Sip1 deletion. While ventral to the CC, the midline closure is complete in the Sip1 mutant; the two hemispheres remain separated dorsally, providing a physical barrier for the callosal axons to cross to the contralateral side, thus resulting in the permanent absence of the CC. The hippocampal axons that project ventral to the CC do not face such a physical barrier at the midline, and manage to project to the contralateral hemisphere.
We have previously shown using the Sip1 fl/fl Emx Cre/wt mutant mice that Sip1 deletion results in a progressive loss of the hippocampus (Miquelajauregui et al., 2007) . This is a degenerative defect resulting from progressive cell death with an onset from E16.5 onward and increasing postnatally. At the developmental stages relevant to this study (E17.5-P7), the hippocampus and the HC are still present, with complete loss occurring only in juveniles, thus making the Sip1-associated hippocampal degeneration irrelevant to the events pertaining to the development of the HC, which occurs around E15.5/E16.5. Neocortical axons frequently branch at specific locations in order to form synapses with multiple targets and establish correct neocortical circuitry (O'Leary and Terashima, 1988) . Different modes of axonal branch formation have been described in vivo, of which the interstitial mode refers to the axonal collateral budding out of the main axonal shaft many days after the growth cone has passed that region (Acebes and Ferrú s, 2000) . In this study we have examined the formation of intracortical axonal collaterals by UL neurons on ipsilateral layer V neurons. We have, to our knowledge, shown for the first time the time course of development of these intracortical collaterals. Although the intercortical callosal projections of UL neurons cross over to the contralateral hemisphere by P0, the intracortical branch formation is initiated only by P4. This delayed emergence of axonal collaterals suggests an interstitial mode of branch formation. Interestingly, Sip1 also controls the timing of the ipsilateral axon collateral formation aiding in the establishment of intracortical connections as well.
The cell-autonomous inability of Sip1-deficient callosal neurons to project to the contralateral hemisphere at the correct developmental stage depends on the protein ninein. Sip1 directly activates the expression of ninein in the cortex. Ninein was discovered in nonneuronal cells as a centrosome-associated protein acting at MT minus end to help anchor the MTs to the centrosome (Bouckson-Castaing et al., 1996) . In polarized cells that show the presence of noncentrosomal MTs, ninein is also found in noncentrosomal locations in association with the MT minus end (Mogensen et al., 2000) . Within the neocortex, ninein is required for the self-renewal of neocortical progenitors in the mouse (Wang et al., 2009) , and for maintenance of progenitor character by anchoring of MTs to the centrosome (Shinohara et al., 2013) . Unlike in progenitors, where ninein is localized to the centrosome, in cortical neurons only noncentrosomal ninein has been observed, and its localization to only the somatodendritic compartment of the cell has been reported (Ohama and Hayashi, 2009 ). The functional role of ninein in neurons has not been characterized so far. In this study we have presented evidence, through immunohistochemistry (IHC) and expression of GFP-tagged protein, that ninein is also present in the axons of cortical neurons. In vivo, ninein is expressed in the WM of the neocortex that corresponds to the fasciculated axons of pyramidal neurons. In cultured cortical neurons, GFP-ninein could be observed in the somatodendritic compartments as well as in the axons and axonal collaterals. These results hence suggest Figure S8 ).
that ninein plays a more extensive role in neurons that is not restricted to the soma and dendrites. Our experiments with re-expression of ninein in Sip1-deficient neurons showed that ninein partially rescued the axon extension defects both in vitro and in vivo. The lack of a complete rescue suggests that there should be other molecules downstream of Sip1 that are involved in the control of axonal growth. It was also interesting to observe that axon collaterals formed by UL neurons at the level of Layer V neurons in the CP were completely restored on expressing ninein in the Sip1-deficient cells. Furthermore, direct downregulation of ninein in wild-type neurons using an shRNA against ninein had a similar effect as Sip1 loss on axonal extension and branching. These experiments together suggest that similar ninein-dependent microtubular mechanisms might be involved in the process of axonal elongation and branching.
Neurons are strongly polarized cells, and the bulk of MTs in neurons are present as free MTs in axons and dendrites, which allows for their characteristic morphology and functionality (Ahmad and Baas, 1995; Keating et al., 1997) . It has been proposed that although the free MTs are not attached to the centrosome at the minus end, in order to remain stable, these MTs bind to other minus end-stabilizing molecules (Keating and Borisy, 1999; Murphy et al., 1977; Stearns and Kirschner, 1994; Zheng et al., 1995) . Although previous findings have indicated that centrosomeassociated ninein plays an important role as a stabilizing molecule for the radial MT asters (Dammermann and Merdes, 2002, Mogensen et al., 2000) , the role of noncentrosomal ninein has not been investigated in great detail. Here we have for the first time shown that noncentrosomal ninein plays an MT-stabilizing role in the axons of neurons. Ninein loss of function, either through Sip1 deletion or direct downregulation through shNinein, severely reduces the stability of the MTs against nocodazole, an MT-destabilizing agent. Re-expression of ninein in Sip1-deficient neurons or overexpressing ninein in wild-type neurons significantly increases their resistance to MT depolymerization. These data correlate to the effects on axon extension and branching wherein conditions with reduced MT stability correspond to reduced axonal length/branching and increased stability to longer axons/more robust branching. These experiments taken together also indicate that stability of MTs is an important contributing factor to the process of axon elongation and branch formation.
The MT cytoskeleton forms the inner scaffold of growing axons. Hence the growth rate of MTs to a large extent determines the growth rate of the axon (Conde and Cá ceres, 2009) . As the growth rate of MTs at the plus end is faster than at the minus end, MT plus end dynamics serves as a good indicator of net MT growth rate (Akhmanova and Steinmetz, 2008) . EB3 being an MT plus-end binding protein enables the tracking of MT plus-end dynamics by using GFP-EB3 (Stepanova et al., 2003) . Plus-end dynamics of MTs was significantly slower in the absence of Sip1 but was restored to wild-type levels when ninein expression was restored, indicating that, apart from MT stability, ninein also influences MT growth. The mechanism by which ninein, being a minus-end binding protein, influences the plus-end dynamics is not evident so far. It could be hypothesized that ninein bound to the minus end of the MT primarily stabilizes the growing MT polymer to which new tubulin dimers are added, and in the absence of ninein, this MT lattice is rendered weak, hence reducing the rate at which polymerization takes place. In support of this hypothesis, presence of MT-destabilizing factors such as nocodazole has been previously shown to reduce MT plus-end growth rate (Vasquez et al., 1997) . Also, a role for a minus-end binding protein in regulating the dynamics of the plus end has been shown with the g-TurC complex in Drosophila S2 cells (Bouissou et al., 2009) .
EXPERIMENTAL PROCEDURES
For list of antibodies, plasmids, and primers used, please refer to Supplemental Information. Nissl staining and IHC were done as described previously (Miquelajauregui et al., 2007; Seuntjens et al., 2009 ).
Mouse Mutants

In Utero Electroporation
The procedure of IUE was performed as described previously (Saito, 2006) .
Chromatin Immunoprecipitation Assay and Luciferase Assay
The ChIP-IT express kit (Active Motif) was used according to the manufacturer's instructions. For the luciferase assay, the PCR products were cloned into pMCS-GL (Thermo Scientific) and transfected along with pCMV-alkaline phosphatase, with or without pCAG-Sip1 in HEK293T cells. Forty-eight hours posttransfection, cell media were assayed using the Secrete-Pair Dual Luminescence assay kit (Genecopoeia) and Glomax luminescence reader (Promega).
Neuron Culture and Nocodazole Assay E16.5/E17.5 embryonic brains were isolated in 13 HBSS followed by trypsinization at 37 C for 30 min and DNase treatment (Worthington). The tissue was then dissociated in Neurobasal media (GIBCO), centrifuged, and resuspended in warm Neurobasal media supplemented with Glutamax, Penicillin-Streptomycin, and B27 (GIBCO). For the nocodazole assay on DIV 2 or DIV 3, 5 mM nocodazole in neurobasal complete medium was added to the neurons. Coverslips were collected 2, 4, 6, and 8 hr after treatment.
Microtubule Plus-End Tracking Using GFP EB3 Cortical neurons expressing GFP-EB3 were cultured on FluroDish tissue culture dish. At DIV 2, live imaging of GFP-EB3 comets was performed using a Zeiss Spinning Disc system CXU-S1 at 1 fps for 200 s and analyzed using the Kymograph ImageJ plug-in.
Statistical Analysis
All data have been represented as mean ± SD. 
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